Hypericum sampsonii induces apoptosis and nuclear export of retinoid X receptor-alpha

Carcinogenesis

Volumn 27, Issue 10, 2006, Pages 1991-2000

  Zeng, Jin Zhang ^a   Sun, De Fun ^a   Wang, Li ^a   Cao, Xihua ^c   Qi, Jian Bin ^b   Yang, Ting ^a   Hu, Chang Qi ^b   Liu, Wen ^c   Zhang, Xiao Kun ^a,c  

^a Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^b FUDAN UNIVERSITY   (China)

^c BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; HYPERICUM SAMPSONII EXTRACT; PLANT EXTRACT; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL NUCLEUS; CELL TRANSPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DRUG EFFICACY; DRUG RESPONSE; ENZYME RELEASE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPERICUM; HYPERICUM SAMPSONII; LIVER CANCER; LUNG CANCER; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; STOMACH CANCER;

ACTIVE TRANSPORT, CELL NUCLEUS; APOPTOSIS; CELL LINE, TUMOR; CELL NUCLEUS; HUMANS; HYPERICUM; PROTEIN TRANSPORT; RETINOID X RECEPTOR ALPHA; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS);

EID: 33749550142     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl046     Document Type: Article

References (59)

1. da Rocha,A.B., Lopes,R.M. and Schwartsmann,G. (2001) Natural products in anticancer therapy. Curr. Opin. Pharmacol., 1, 364-369.
2. Newman,D.J., Cragg,G.M. and Snader,K.M. (2003) Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod., 66, 1022-1037.
3. Koehn,F.E. and Carter,G.T. (2005) The evolving role of natural products in drug discovery. Nat. Rev. Drug Discov., 4, 206-220.
4. Archer,J.R. (2004) History, evolution, and trends in compound management for high throughput screening. Assay Drug Dev. Technol., 2, 675-681.
5. Lazar,M.A. (2004) East meets West: An herbal tea finds a receptor. J. Clin. Invest., 113, 23-25.
6. Nagle,D.G., Zhou,Y.D., Mora,F.D., Mohammed,K.A. and Kim,Y.P. (2004) Mechanism targeted discovery of antitumor marine natural products. Curr. Med. Chem., 11, 1725-1756.
7. Novac,N. and Heinzel,T. (2004) Nuclear receptors: Overview and classification. Curr. Drug Targets Inflamm Allergy, 3, 335-346.
8. Nagy,L. and Schwabe,J.W. (2004) Mechanism of the nuclear receptor molecular switch. Trends Biochem. Sci., 29, 317-324.
9. Chawla,A., Repa,J.J., Evans,R.M. and Mangelsdorf,D.J. (2001) Nuclear receptors and lipid physiology: Opening the X-files. Science, 294, 1866-1870.
10. Schapira,M. (2002) Pharmacogenomics opportunities in nuclear receptor targeted cancer therapy. Curr. Cancer Drug Targets, 2, 243-256.
11. Gronemeyer,H., Gustafsson,J.A. and Laudet,V. (2004) Principles for modulation of the nuclear receptor superfamily. Nat. Rev. Drug Discov., 3, 950-964.
12. Kastner,P., Mark,M. and Chambon,P. (1995) Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell, 83, 859-869.
13. Mangelsdorf,D.J., Thummel,C., Beato,M. et al. (1995) The nuclear receptor superfamily: The second decade. Cell, 83, 835-839.
14. Xu,L., Glass,C.K. and Rosenfeld,M.G. (1999) Coactivator and corepressor complexes in nuclear receptor function. Curr. Opin. Genet. Dev., 9, 140-147.
15. Zhang,X.K., Hoffmann,B., Tran,P.B., Graupner,G. and Pfahl,M. (1992) Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature, 355, 441-446.
16. Zhang,X.K., Lehmann,J., Hoffmann,B., Dawson,M.I., Cameron,J., Graupner,G., Hermann,T., Tran,P. and Pfahl,M. (1992) Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature, 358, 587-591.
17. Zhang,X.K. and Pfahl,M. (1993) Hetero- and homodimeric receptors in thyroid hormone and vitamin A action. Receptor, 3, 183-191.
18. Love,J.D., Gooch,J.T., Benko,S., Li,C., Nagy,L., Chatterjee,V.K., Evans,R.M. and Schwabe,J.W. (2002) The structural basis for the specificity of retinoid-X receptor-selective agonists: New insights into the role of helix H12. J. Biol. Chem., 277, 11385-11391.
19. Szanto,A., Narkar,V., Shen,Q., Uray,I.P., Davies,P.J. and Nagy,L. (2004) Retinoid X receptors: X-ploring their (patho)physiological functions. Cell Death Differ., 11 (Suppl. 2), S126-S143.
20. Huang,J., Powell,W.C., Khodavirdi,A.C., Wu,J., Makita,T., Cardiff,R.D., Cohen,M.B., Sucov,H.M. and Roy-Burman,P. (2002) Prostatic intraepithelial neoplasia in mice with conditional disruption of the retinoid X receptor alpha allele in the prostate epithelium. Cancer Res., 62, 4812-4819.
21. Li,M., Indra,A.K., Warot,X., Brocard,J., Messaddeq,N., Kato,S., Metzger,D. and Chambon,P. (2000) Skin abnormalities generated by temporally controlled RXRalpha mutations in mouse epidermis. Nature, 407, 633-636.
22. Li,M., Chiba,H., Warot,X., Messaddeq,N., Gerard,C., Chambon,P. and Metzger,D. (2001) RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development, 128, 675-688.
23. Mao,G.E., Reuter,V.E., Cordon-Cardo,C., Dalbagni,G., Scher,H.I., DeKernion,J.B., Zhang,Z.F. and Rao,J. (2004) Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development. Cancer Epidemiol. Biomarkers Prev., 13, 383-390.
24. Li,H., Kolluri,S.K., Gu,J. et al. (2000) Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3. Science, 289, 1159-1164.
25. Heyman,R.A., Mangelsdorf,D.J., Dyck,J.A., Stein,R.B., Eichele,G., Evans,R.M. and Thaller,C. (1992) 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68, 397-406.
26. de Urquiza,A.M., Liu,S., Sjoberg,M., Zetterstrom,R.H., Griffiths,W., Sjovall,J. and Perlmann,T. (2000) Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science, 290, 2140-2144.
27. Lengqvist,J., Mata De Urquiza,A., Bergman,A.C., Willson,T.M., Sjovall,J., Perlmann,T. and Griffiths,W.J. (2004) Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain. Mol. Cell. Proteomics, 3, 692-703.
28. Goldstein,J.T., Dobrzyn,A., Clagett-Dame,M., Pike,J.W. and DeLuca,H.F. (2003) Isolation and characterization of unsaturated fatty acids as natural ligands for the retinoid-X receptor. Arch Biochem. Biophys, 420, 185-193.
29. Khuri,F.R., Rigas,J.R., Figlin,R.A. et al. (2001) Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer. J. Clin. Oncol., 19, 2626-2637.
30. Lemotte,P.K., Keidel,S. and Apfel,C.M. (1996) Phytanic acid is a retinoid X receptor ligand. Eur. J. Biochem., 236, 328-333.
31. Kitareewan,S., Burka,L.T., Tomer,K.B. et al. (1996) Phytol metabolites are circulating dietary factors that activate the nuclear receptor RXR. Mol. Biol. Cell, 7, 1153-1166.
32. Kolluri,S.K., Corr,M., James,S.Y., Bernasconi,M., Lu,D., Liu,W., Cottam,H.B., Leoni,L.M., Carson,D.A. and Zhang,X.K. (2005) The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Proc. Natl Acad. Sci. USA, 102, 2525-2530.
33. Pruf̈er,K. and Barsony,J. (2002) Retinoid X receptor dominates the nuclear import and export of the unliganded vitamin D receptor. Mol. Endocrinol., 16, 1738-1751.
34. Lin,X.F., Zhao,B.X., Chen,H.Z., Ye,X.F., Yang,C.Y., Zhou,H.Y., Zhang,M.Q., Lin,S.C. and Wu,Q. (2004) RXR (acts as a carrier for TR3 nuclear export in a 9-cis retinoic acid-dependent manner in gastric cancer cells. J. Cell Sci., 117, 5609-5621.
35. Dufour,J.M. and Kim,K.H. (1999) Cellular and subcellular localization of six retinoid receptors in rat testis during postnatal development: identification of potential heterodimeric receptors. Biol. Reprod., 61, 1300-1308.
36. Boulogne,B., Levacher,C., Durand,P. and Habert,R. (1999) Retinoic acid receptors and retinoid X receptors in the rat testis during fetal and postnatal development: Immunolocalization and implication in the control of the number of gonocytes. Biol. Reprod., 61, 1548-1557.
37. Katagiri,Y., Takeda,K., Yu,Z.X., Ferrans,V.J., Ozato,K. and Guroff,G. (2000) Modulation of retinoid signalling through NGF-induced nuclear export of NGFI-B. Nat. Cell Biol., 2, 435-440.
38. Casas,F., Daury,L., Grandemange,S., Busson,M., Seyer,P., Hatier,R., Carazo,A., Cabello,G. and Wrutniak-Cabello,C. (2003) Endocrine regulation of mitochondrial activity: Involvement of truncated RXRalpha and c-ErbA alpha1 proteins. FASEB J., 17, 426-436.
39. Cao,X., Liu,W., Lin,F., Li,H., Kolluri,S.K., Lin,B., Han,Y.H., Dawson,M.I. and Zhang,X.K. (2004) Retinoid X receptor regulates Nur77/ TR3-dependent apoptosis [corrected] by modulating its nuclear export and mitochondrial targeting. Mol. Cell. Biol., 24, 9705-9725.
40. Lee,K.W., Ma,L., Yan,X., Liu,B., Zhang,X.K. and Cohen,P. (2005) Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77. J. Biol. Chem., 280, 16942-16948.
41. Lin,B., Kolluri,S.K., Lin,F., Liu,W., Han,Y.H., Cao,X., Dawson,M.I., Reed,J.C. and Zhang,X.K. (2004) Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell, 116, 527-540.
42. Jacobs,C.M. and Paulsen,R.E. (2005) Crosstalk between ERK2 and RXR regulates nuclear import of transcription factor NGFI-B. Biochem. Biophys. Res. Commun., 336, 646-652.
43. Kirakosyan,A., Sirvent,T.M., Gibson,D.M. and Kaufman,P.B. (2004) The production of hypericins and hyperforin by in vitro cultures of St John's wort (Hypericum perforatum). Biotechnol. Appl. Biochem., 39, 71-81.
44. Don,M.J., Huang,Y.J., Huang,R.L. and Lin,Y.L. (2004) New phenolic principles from Hypericum sampsonii. Chem. Pharm. Bull. (Tokyo), 52, 866-869.
45. Hong,D., Yin,F., Hu,L.H. and Lu,P. (2004) Sulfonated xanthones from Hypericum sampsonii. Phytochemistry, 65, 2595-2598.
46. Di Carlo,G., Borrelli,F., Ernst,E. and Izzo,A.A. (2001) St John's wort: prozac from the plant kingdom. Trends Pharmacol. Sci., 22, 292-297.
47. Muller,W.E. (2003) Current St John's wort research from mode of action to clinical efficacy. Pharmacol Res., 47, 101-109.
48. Agostinis,P., Vantieghem,A., Merlevede,W. and de Witte,P.A. (2002) Hypericin in cancer treatment: More light on the way. Int. J. Biochem. Cell Biol., 34, 221-241.
49. Schempp,C.M., Kirkin,V., Simon-Haarhaus,B. et al. (2002) Inhibition of tumour cell growth by hyperforin, a novel anticancer drug from St John's wort that acts by induction of apoptosis. Oncogene, 21, 1242-1250.
50. Wu,Q., Li,Y., Liu,R., Agadir,A., Lee,M.O., Liu,Y. and Zhang,X. (1997) Modulation of retinoic acid sensitivity in lung cancer cells through dynamic balance of orphan receptors nur77 and COUP-TF and their heterodimerization. EMBO J., 16, 1656-1669.
51. Wu,Q., Dawson,M.I., Zheng,Y., Hobbs,P.D., Agadir,A., Jong,L., Li,Y., Liu,R., Lin,B. and Zhang,X.K. (1997) Inhibition of trans-retinoic acid-resistant human breast cancer cell growth by retinoid X receptor-selective retinoids. Mol. Cell. Biol., 17, 6598-6608.
52. Kroemer,G. and Reed,J.C. (2000) Mitochondrial control of cell death. Nat. Med., 6, 513-519.
53. Moore,L.B., Goodwin,B., Jones,S.A., Wisely,G.B., Serabjit-Singh,C.J., Willson,T.M., Collins,J.L. and Kliewer,S.A. (2000) St John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc. Natl Acad. Sci. USA, 97, 7500-7502.
54. Wentworth,J.M., Agostini,M., Love,J., Schwabe,J.W. and Chatterjee,V.K. (2000) St John's wort, a herbal antidepressant, activates the steroid X receptor. J. Endocrinol., 166, R11-R16.
55. Kolluri,S.K., Bruey-Sedano,N., Cao,X., Lin,B., Lin,F., Han,Y.H., Dawson,M.I. and Zhang,X.K. (2003) Mitogenic effect of orphan receptor TR3 and its regulation by MEKK1 in lung cancer cells. Mol. Cell. Biol., 23, 8651-8667.
56. Bourguet,W., Andry,V., Iltis,C., Klaholz,B., Potier,N., Van Dorsselaer,A., Chambon,P., Gronemeyer,H. and Moras,D. (2000) Heterodimeric complex of RAR and RXR nuclear receptor ligand-binding domains: Purification, crystallization, and preliminary X-ray diffraction analysis. Protein Expr. Purif., 19, 284-288.
57. Han,Y.H., Cao,X., Lin,B., Lin,F., Kolluri,S.K., Stebbins,J., Reed,J.C., Dawson,M.I. and Zhang,X.K. (2006) Regulation of Nur77 nuclear export by c-Jun N-terminal kinase and Akt. Oncogene, [Epub ahead of print] PMID: 16434970.
58. Bourguet,W., Vivat,V., Wurtz,J.M., Chambon,P., Gronemeyer,H. and Moras,D. (2000) Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. Mol. Cell, 5, 289-298.
59. Egea,P.F., Mitschler,A., Rochel,N., Ruff,M., Chambon,P. and Moras,D. (2000) Crystal structure of the human RXRalpha ligand-binding domain bound to its natural ligand: 9-cis retinoic acid. EMBO J., 19, 2592-2601.